Five Prime Therapeutics Inc (FPRX) Gross Profit Margin starting from the fourth quarter 2020 to fourth quarter 2019, Profitability Trends and Ranking, Fundamental Ratios - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 


• Gross Margin
• EBITDA Margin
• Operating Margin
• Net Margin
• Pre-Tax Margin
• Effective Tax Rate
• Free Cash Flow Margin
• Cash Flow Margin
Five Prime Therapeutics Inc   (NASDAQ: FPRX)


Five Prime Therapeutics Inc 's Gross Profit Margin by quarter

Trends, Rankings, Statistics


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

FPRX Gross Profit Margin (Dec 31 2020)
Q4 		(Sep 30 2020)
Q3 		(Jun 30 2020)
Q2 		(Mar 31 2020)
Q1 		(Dec 31 2019)
Q4
Y / Y Revenue Change -
Seq. Revenue Change -
Revenue In Millions $-0.71
Gross Profit Margin -
Gross Profit Margin Total Ranking #
Gross Profit In Millions $-0.71
Y / Y Gross Profit Change -
Seq. Gross Profit Change -


Commenting fourth quarter 2020 Gross Profit Margin
Learn about Gross Margin
FPRX's Gross Profit Margin fourth quarter 2020 Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall # 0

Gross Profit Margin Statistics
High Average Low
0 % 0 % 0 %
 


FPRX Gross Income Trends • More of FPRX's Profitabilty Ratios • FPRX Stock Quotes and Charts


Other Gross Profit Margin Profitability Ratios
FPRX's Cumulative Gross Profit Margin
Major Pharmaceutical Preparations Industry Gross Profit Margin Trends and Statistics
Healthcare Sector Gross Profit Margin Statistics
Gross Profit Margin Profitability Trends for overall market
FPRX's Gross Profit Margin Profitability versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Gross Profit Margin
Lowest Ranking Gross Profit Margin
Gross Profit Margin Profit Margin for FPRX's Competitors
Gross Profit Margin Profit Margin for Five Prime Therapeutics Inc 's Suppliers
Gross Profit Margin Profit Margin for FPRX's Customers

You may also want to know
FPRX's Annual Growth Rates FPRX's Profitability Ratios FPRX's Asset Turnover Ratio FPRX's Dividend Growth
FPRX's Roe FPRX's Valuation Ratios FPRX's Financial Strength Ratios FPRX's Gross Profit Growth
FPRX's Roa FPRX's Inventory Turnover Ratio FPRX's Growth Rates FPRX's Dividend Comparisons


Companies with similar Gross Profit Margin in the quarter ending Dec 31 2020, within Major Pharmaceutical Preparations Industry Gross Profit MarginDec 31 2020 MRQ Gross ProfitDec 31 2020 MRQ Revenue
Skinvisible Inc   101.28 %$ 0.133  Millions$ 0.131  Millions
Sage Therapeutics Inc   99.99 %$ 1,109.050  Millions$ 1,109.186  Millions
Alpine Immune Sciences Inc   99.81 %$ 5.632  Millions$ 5.643  Millions
Ardelyx inc   99.78 %$ 1.805  Millions$ 1.809  Millions
Deciphera Pharmaceuticals Inc   99.35 %$ 19.359  Millions$ 19.486  Millions
Ironwood Pharmaceuticals inc   99.23 %$ 115.783  Millions$ 116.680  Millions
Intercept Pharmaceuticals inc   99.08 %$ 82.501  Millions$ 83.268  Millions
Bellicum Pharmaceuticals Inc   99.00 %$ 0.495  Millions$ 0.500  Millions
Ionis Pharmaceuticals Inc   98.86 %$ 286.980  Millions$ 290.281  Millions
Corcept Therapeutics Inc  98.54 %$ 84.481  Millions$ 85.735  Millions
Ultragenyx Pharmaceutical Inc   98.33 %$ 90.017  Millions$ 91.542  Millions
Acadia Pharmaceuticals Inc   97.93 %$ 118.499  Millions$ 121.007  Millions
Agios Pharmaceuticals Inc   97.82 %$ 43.086  Millions$ 44.045  Millions
Global Blood Therapeutics Inc.  97.67 %$ 40.334  Millions$ 41.295  Millions
Morphosys Ag  97.20 %$ 356.747  Millions$ 367.022  Millions
Adamas Pharmaceuticals Inc  97.16 %$ 20.413  Millions$ 21.010  Millions
Avalo Therapeutics Inc   94.69 %$ 1.417  Millions$ 1.496  Millions
Rigel Pharmaceuticals Inc  94.48 %$ 17.432  Millions$ 18.450  Millions
Chiasma Inc   93.98 %$ 0.906  Millions$ 0.964  Millions
Shattuck Labs Inc   92.76 %$ 1.245  Millions$ 1.342  Millions
Serina Therapeutics Inc   92.48 %$ 0.467  Millions$ 0.505  Millions
Ainos Inc   91.85 %$ 0.001  Millions$ 0.001  Millions
Jazz Pharmaceuticals Plc  91.83 %$ 611.146  Millions$ 665.517  Millions
Urogen Pharma Ltd   91.82 %$ 7.314  Millions$ 7.966  Millions
United Therapeutics Corporation  90.96 %$ 350.100  Millions$ 384.900  Millions
Ocular Therapeutix Inc   90.75 %$ 6.669  Millions$ 7.349  Millions
Alexion Pharmaceuticals Inc   90.44 %$ 1,439.600  Millions$ 1,591.800  Millions
Vanda Pharmaceuticals Inc   89.98 %$ 60.871  Millions$ 67.653  Millions
Pharming Group N v   88.91 %$ 184.904  Millions$ 207.977  Millions
Siga Technologies Inc  88.52 %$ 33.397  Millions$ 37.729  Millions




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.